002173 创新医疗
午间休市 05-06 11:30:00
资讯
新帖
简况
股市必读:创新医疗(002173)股东户数15.1万户,较上期增加33.86%
证券之星 · 02:18
股市必读:创新医疗(002173)股东户数15.1万户,较上期增加33.86%
每周股票复盘:创新医疗(002173)股东户数增33.86%,一季度净利降80.45%
证券之星 · 05-03
每周股票复盘:创新医疗(002173)股东户数增33.86%,一季度净利降80.45%
创新医疗(002173.SZ)发布一季度业绩,归母净亏损2514.97万元
智通财经 · 04-29
创新医疗(002173.SZ)发布一季度业绩,归母净亏损2514.97万元
创新医疗(002173)披露为鸿润医药提供800万元授信担保公告,4月29日股价上涨1.09%
证券之星 · 04-29
创新医疗(002173)披露为鸿润医药提供800万元授信担保公告,4月29日股价上涨1.09%
图解创新医疗一季报:第一季度单季净利润同比下降80.45%
证券之星 · 04-29
图解创新医疗一季报:第一季度单季净利润同比下降80.45%
股市必读:创新医疗年报 - 第四季度单季净利润同比增长40.13%
证券之星 · 04-27
股市必读:创新医疗年报 - 第四季度单季净利润同比增长40.13%
图解创新医疗年报:第四季度单季净利润同比增长40.13%
证券之星 · 04-25
图解创新医疗年报:第四季度单季净利润同比增长40.13%
创新医疗(002173)披露股东所持部分限售股份解除限售公告,3月23日股价下跌7.28%
证券之星 · 03-23
创新医疗(002173)披露股东所持部分限售股份解除限售公告,3月23日股价下跌7.28%
中银创新医疗混合A基金经理变动:郑宁不再担任该基金基金经理
证券之星 · 03-19
中银创新医疗混合A基金经理变动:郑宁不再担任该基金基金经理
中银国际:全球首款侵入式脑机产品获批 行业迈入商业化验证期
智通财经 · 03-16
中银国际:全球首款侵入式脑机产品获批 行业迈入商业化验证期
中银创新医疗混合A基金经理变动:增聘李文广为基金经理
证券之星 · 03-06
中银创新医疗混合A基金经理变动:增聘李文广为基金经理
异动快报:创新医疗(002173)3月3日14点46分触及跌停板
中金财经 · 03-03
异动快报:创新医疗(002173)3月3日14点46分触及跌停板
创新医疗(002173)披露2025年度业绩预告,1月29日股价上涨1.88%
证券之星 · 01-29
创新医疗(002173)披露2025年度业绩预告,1月29日股价上涨1.88%
创新医疗(002173)披露诉讼事项进展公告,1月23日股价上涨3.28%
证券之星 · 01-23
创新医疗(002173)披露诉讼事项进展公告,1月23日股价上涨3.28%
创新医疗(002173)披露股票交易异常波动公告,1月12日股价上涨6.78%
证券之星 · 01-12
创新医疗(002173)披露股票交易异常波动公告,1月12日股价上涨6.78%
创新医疗最新公告:博灵脑机产品赛博灵科AC5已于2025年10月正式上市销售2025年共实现收入11.40万元
证券之星 · 01-12
创新医疗最新公告:博灵脑机产品赛博灵科AC5已于2025年10月正式上市销售2025年共实现收入11.40万元
1月12日创新医疗(002173)龙虎榜数据:机构净买入3031.17万元,北向资金净卖出1.34亿元
证券之星 · 01-12
1月12日创新医疗(002173)龙虎榜数据:机构净买入3031.17万元,北向资金净卖出1.34亿元
1月9日创新医疗(002173)龙虎榜数据:机构净买入1.05亿元,北向资金净买入2.88亿元
证券之星 · 01-09
1月9日创新医疗(002173)龙虎榜数据:机构净买入1.05亿元,北向资金净买入2.88亿元
异动快报:创新医疗(002173)1月9日9点43分触及涨停板
证券之星 · 01-09
异动快报:创新医疗(002173)1月9日9点43分触及涨停板
宜明昂科与Axion“分手”;江西省卫健委党组书记被查
21世纪经济报道 · 01-08
宜明昂科与Axion“分手”;江西省卫健委党组书记被查
加载更多
公司概况
公司名称:
创新医疗管理股份有限公司
所属行业:
卫生
上市日期:
2007-09-25
主营业务:
创新医疗管理股份有限公司的主营业务是提供医疗服务。公司的主要产品是医疗服务业务、其他业务。
发行价格:
11.30
{"stockData":{"symbol":"002173","market":"SZ","secType":"STK","nameCN":"创新医疗","latestPrice":24.08,"timestamp":1778039727000,"preClose":23.26,"halted":0,"volume":14457272,"delay":0,"changeRate":0.0353,"floatShares":421000000,"shares":441000000,"eps":-0.1044,"marketStatus":"午间休市","change":0.82,"latestTime":"05-06 11:30:00","open":23.39,"high":24.17,"low":23.39,"amount":344000000,"amplitude":0.0335,"askPrice":24.12,"askSize":32,"bidPrice":24.08,"bidSize":174,"shortable":0,"etf":0,"ttmEps":-0.1044,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778043600000},"marketStatusCode":3,"adr":0,"adjPreClose":23.26,"symbolType":"stock","openAndCloseTimeList":[[1778031000000,1778038200000],[1778043600000,1778050800000]],"highLimit":25.59,"lowLimit":20.93,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":441284352,"isCdr":false,"pbRate":5.95,"roa":"--","roe":"--","epsLYR":-0.08,"committee":-0.239247,"marketValue":10626000000,"turnoverRate":0.0344,"status":0,"floatMarketCap":10134000000},"requestUrl":"/m/hq/s/002173","defaultTab":"news","newsList":[{"id":"2633928362","title":"股市必读:创新医疗(002173)股东户数15.1万户,较上期增加33.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633928362","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633928362?lang=zh_cn&edition=full","pubTime":"2026-05-06 02:18","pubTimestamp":1778005096,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,创新医疗报收于23.26元,上涨0.3%,换手率3.5%,成交量14.72万手,成交额3.41亿元。来自公司公告汇总:董事会审议通过为浙江鸿润医药有限公司提供不超过800万元授信担保的议案。股本股东变化股东户数变动截至2026年3月31日,公司股东户数为15.1万户,较2025年12月31日增加3.82万户,增幅33.86%;户均持股数量由3911.0股下降至2922.0股,户均持股市值为7.28万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600000707.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002173","BK0077","BK0114","BK0096","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632746536","title":"每周股票复盘:创新医疗(002173)股东户数增33.86%,一季度净利降80.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632746536","media":"证券之星","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632746536?lang=zh_cn&edition=full","pubTime":"2026-05-03 02:59","pubTimestamp":1777748346,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,创新医疗报收于23.26元,较上周的24.11元下跌3.53%。本周,创新医疗4月27日盘中最高价报23.95元。业绩披露要点:一季度归母净利润为-2514.97万元,同比下降80.45%。股本股东变化股东户数变动截至2026年3月31日,创新医疗股东户数为15.1万户,较2025年12月31日增加3.82万户,增幅33.86%。户均持股数量由3911.0股降至2922.0股,户均持股市值为7.28万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300000543.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0077","BK0236","002173","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631468665","title":"创新医疗(002173.SZ)发布一季度业绩,归母净亏损2514.97万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2631468665","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631468665?lang=zh_cn&edition=full","pubTime":"2026-04-29 23:09","pubTimestamp":1777475379,"startTime":"0","endTime":"0","summary":"智通财经APP讯,创新医疗(002173.SZ)发布2026年第一季度报告,第一季度,公司实现营业收入1.67亿元,同比下降13.80%。归属于上市公司股东净亏损2514.97万元。归属于上市公司股东的扣除非经常性损益净亏损2528.74万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436749.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0236","BK0114","BK0096","BK0077","002173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631543800","title":"创新医疗(002173)披露为鸿润医药提供800万元授信担保公告,4月29日股价上涨1.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631543800","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631543800?lang=zh_cn&edition=full","pubTime":"2026-04-29 22:19","pubTimestamp":1777472360,"startTime":"0","endTime":"0","summary":"截至2026年4月29日收盘,创新医疗报收于23.19元,较前一交易日上涨1.09%,最新总市值为102.33亿元。该股当日开盘22.62元,最高23.29元,最低22.6元,成交额达3.35亿元,换手率为3.44%。近日,创新医疗管理股份有限公司披露《第七届董事会2026年第二次临时会议决议公告》。公司决定为浙江鸿润医药有限公司在800万元授信额度内向招商银行绍兴诸暨支行申请贷款提供担保。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900068941.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","BK0077","BK1161","09939","002173","BK0114","BK1515","BK0096","159938","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631511285","title":"图解创新医疗一季报:第一季度单季净利润同比下降80.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631511285","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631511285?lang=zh_cn&edition=full","pubTime":"2026-04-29 20:36","pubTimestamp":1777466214,"startTime":"0","endTime":"0","summary":"证券之星消息,创新医疗2026年一季报显示,一季度公司主营收入1.67亿元,同比下降13.8%;归母净利润-2514.97万元,同比下降80.45%;扣非净利润-2528.74万元,同比下降68.92%;负债率18.59%,投资收益-119.32万元,财务费用-0.37万元,毛利率2.48%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900062122.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630069333","title":"股市必读:创新医疗年报 - 第四季度单季净利润同比增长40.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630069333","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630069333?lang=zh_cn&edition=full","pubTime":"2026-04-27 01:18","pubTimestamp":1777223892,"startTime":"0","endTime":"0","summary":"股本股东变化股东户数变动近日创新医疗披露,截至2026年3月31日公司股东户数为15.1万户,较12月31日增加3.82万户,增幅为33.86%。公司公告汇总2025年年度报告摘要创新医疗管理股份有限公司2025年年度报告摘要显示,截至2025年末,公司总资产为2,179,116,674.47元,归属于上市公司股东的净资产为1,749,891,597.45元。董事会决定2025年度不进行利润分配,也不以资本公积金转增股本。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700003237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630485829","title":"图解创新医疗年报:第四季度单季净利润同比增长40.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630485829","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630485829?lang=zh_cn&edition=full","pubTime":"2026-04-25 01:01","pubTimestamp":1777050077,"startTime":"0","endTime":"0","summary":"证券之星消息,创新医疗2025年年报显示,当年度公司主营收入7.81亿元,同比下降4.26%;归母净利润-3485.45万元,同比上升62.9%;扣非净利润-7902.88万元,同比下降32.66%;其中2025年第四季度,公司单季度主营收入1.84亿元,同比下降10.63%;单季度归母净利润-3957.89万元,同比上升40.13%;单季度扣非净利润-4955.9万元,同比下降75.71%;负债率19.03%,投资收益3215.56万元,财务费用59.75万元,毛利率6.91%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042500003146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621170105","title":"创新医疗(002173)披露股东所持部分限售股份解除限售公告,3月23日股价下跌7.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621170105","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621170105?lang=zh_cn&edition=full","pubTime":"2026-03-23 22:05","pubTimestamp":1774274727,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘,创新医疗报收于24.85元,较前一交易日下跌7.28%,最新总市值为109.66亿元。近日,公司发布《关于股东所持公司部分限售股份解除限售的公告》。康瀚投资为业绩承诺方,其所持股份在锁定期满后仍处于限售状态。2024年12月11日,韩猛通过司法执行过户取得康瀚投资持有的450万股限售股份。2025年2月,韩猛起诉公司要求办理解除限售手续。2026年3月23日,韩猛所持4,275,513股股票被司法强制解限并上市流通。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300039572.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002173","BK0236","BK0096","BK0114","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620292308","title":"中银创新医疗混合A基金经理变动:郑宁不再担任该基金基金经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2620292308","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620292308?lang=zh_cn&edition=full","pubTime":"2026-03-19 09:31","pubTimestamp":1773883897,"startTime":"0","endTime":"0","summary":"证券之星消息,2026年3月19日,中银创新医疗混合(007718)发布公告,郑宁不再担任该基金基金经理,离任日期为2026年3月19日,变更后中银创新医疗混合(007718)的基金经理为李文广。截止2026年3月18日,中银创新医疗混合净值为2.0623,较上一日上涨1.66%,近一年上涨39.51%。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031900007195.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002173","BK0077","BK0236","BK0096","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619458178","title":"中银国际:全球首款侵入式脑机产品获批 行业迈入商业化验证期","url":"https://stock-news.laohu8.com/highlight/detail?id=2619458178","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619458178?lang=zh_cn&edition=full","pubTime":"2026-03-16 16:05","pubTimestamp":1773648327,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,中银国际发布研报称,近日,国家药监局批准博睿康植入式脑机接口手部运动功能代偿系统创新产品注册申请,实现脑机接口全球首发上市,标志中国脑机接口产业从“技术验证”迈向“商业化落地”。投资建议随着全球首款侵入式产品获批上市,国内脑机接口产业已进入商业化验证期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414283.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"中银国际:全球首款侵入式脑机产品获批 行业迈入商业化验证期","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0236","301363","BK0114","688580","BK0096","BK0251","301293","301087","300753","688273","BK0077","688626","002173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617505389","title":"中银创新医疗混合A基金经理变动:增聘李文广为基金经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2617505389","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617505389?lang=zh_cn&edition=full","pubTime":"2026-03-06 09:31","pubTimestamp":1772760662,"startTime":"0","endTime":"0","summary":"证券之星消息,2026年3月6日,中银创新医疗混合发布公告,增聘李文广为基金经理,任职日期自2026年3月6日起,变更后中银创新医疗混合的基金经理为李文广,郑宁。截止2026年3月5日,中银创新医疗混合净值为1.8726,较上一日上涨2.67%,近一年上涨28.25%。2017年加入中银基金管理有限公司,曾任研究员。2025年12月15日担任中银民利一年持有期债券型证券投资基金基金经理。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030600008015.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0114","002173","BK0236","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616666319","title":"异动快报:创新医疗(002173)3月3日14点46分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2616666319","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616666319?lang=zh_cn&edition=full","pubTime":"2026-03-03 15:18","pubTimestamp":1772522282,"startTime":"0","endTime":"0","summary":"证券之星3月3日盘中消息,14点46分创新医疗(002173)触及跌停板。其所属行业医疗服务目前下跌。该股为优化生育(三孩),医美,眼科概念热股。3月2日的资金流向数据方面,主力资金净流出1.06亿元,占总成交额7.04%,游资资金净流入634.26万元,占总成交额0.42%,散户资金净流入9991.78万元,占总成交额6.62%。近5日资金流向一览见下表: 创新医疗主要指标及行业内排名如下: 为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202603/03/20260303236929.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202603/03/20260303236929.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260303/32040772.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["002173","BK0096","BK0077","BK0236","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607033158","title":"创新医疗(002173)披露2025年度业绩预告,1月29日股价上涨1.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607033158","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607033158?lang=zh_cn&edition=full","pubTime":"2026-01-29 22:09","pubTimestamp":1769695756,"startTime":"0","endTime":"0","summary":"截至2026年1月29日收盘,创新医疗报收于28.71元,较前一交易日上涨1.88%,最新总市值为126.69亿元。该股当日开盘27.98元,最高29.91元,最低27.9元,成交额达19.4亿元,换手率为15.98%。营业收入预计为78,000万元至80,000万元,上年同期为81,601.88万元。最终数据以经审计的2025年年度报告为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900043225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002173","BK0236","BK0096","BK0114","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605440546","title":"创新医疗(002173)披露诉讼事项进展公告,1月23日股价上涨3.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605440546","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605440546?lang=zh_cn&edition=full","pubTime":"2026-01-23 22:18","pubTimestamp":1769177928,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘,创新医疗报收于29.88元,较前一交易日上涨3.28%,最新总市值为131.86亿元。该股当日开盘30.0元,最高30.45元,最低28.75元,成交额达23.03亿元,换手率为18.59%。近日,创新医疗管理股份有限公司披露《关于诉讼事项的进展公告(三)》。法院判决驳回上诉,维持原判。二审案件受理费193,877元,由韩猛负担9,672元,公司负担184,205元。截至公告日,公司及控股子公司不存在应披露而未披露的其他重大诉讼、仲裁事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300042988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0077","BK0236","002173","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602545328","title":"创新医疗(002173)披露股票交易异常波动公告,1月12日股价上涨6.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602545328","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602545328?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:01","pubTimestamp":1768226476,"startTime":"0","endTime":"0","summary":"截至2026年1月12日收盘,创新医疗报收于36.99元,较前一交易日上涨6.78%,最新总市值为163.23亿元。该股当日开盘35.4元,最高38.1元,最低34.0元,成交额达70.25亿元,换手率为46.32%。公司近日发布公告称,股票于2026年1月8日、9日、12日连续三个交易日内日收盘价格涨幅偏离值累计超过20%,构成交易异常波动。控股股东及实际控制人在股票交易异常波动期间未买卖公司股票。公司董事会确认,目前没有应披露而未披露的事项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200036595.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002173","BK0077","BK0114","BK0096","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602338519","title":"创新医疗最新公告:博灵脑机产品赛博灵科AC5已于2025年10月正式上市销售2025年共实现收入11.40万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602338519","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602338519?lang=zh_cn&edition=full","pubTime":"2026-01-12 19:01","pubTimestamp":1768215710,"startTime":"0","endTime":"0","summary":"公司控股子公司博灵脑机(杭州)科技有限公司成立于2021年年初,并于2025年8月被公司纳入合并报表范围,当前产品主要用于脑血管疾病患者在医疗机构进行康复训练以及出院后在居家情况下的运动功能辅助和增强。博灵脑机产品赛博灵科AC5已于2025年10月正式上市销售,2025年共实现收入11.40万元;赛博灵科AM5已完成多中心临床试验,2025年尚未实现收入。2023年、2024年,博灵脑机的经营亏损分别为660.17万元、866.41万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200029915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","002173","BK0114","BK0077","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602330513","title":"1月12日创新医疗(002173)龙虎榜数据:机构净买入3031.17万元,北向资金净卖出1.34亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602330513","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602330513?lang=zh_cn&edition=full","pubTime":"2026-01-12 17:46","pubTimestamp":1768211176,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年1月12日公布的交易公开信息显示,创新医疗因连续三个交易日内,涨幅偏离值累计达到20%的证券,日换手率达到20%的前5只证券登上龙虎榜。此次是近5个交易日内第3次上榜。截至2026年1月12日收盘,创新医疗报收于36.99元,上涨6.78%,换手率46.32%,成交量192.83万手,成交额70.25亿元。从龙虎榜公布的当日买卖数据来看,机构合计净买入3031.17万元,北向资金合计净卖出1.34亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200024901.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0236","BK0077","002173","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602490329","title":"1月9日创新医疗(002173)龙虎榜数据:机构净买入1.05亿元,北向资金净买入2.88亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602490329","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602490329?lang=zh_cn&edition=full","pubTime":"2026-01-09 17:33","pubTimestamp":1767951218,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年1月9日公布的交易公开信息显示,创新医疗因日涨幅偏离值达到7%的前5只证券,日换手率达到20%的前5只证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2026年1月9日收盘,创新医疗报收于34.64元,上涨10.0%,换手率42.68%,成交量177.67万手,成交额60.66亿元。从龙虎榜公布的当日买卖数据来看,机构合计净买入1.05亿元,北向资金合计净买入2.88亿元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900028663.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","002173","BK0114","BK0096","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602352310","title":"异动快报:创新医疗(002173)1月9日9点43分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2602352310","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602352310?lang=zh_cn&edition=full","pubTime":"2026-01-09 09:45","pubTimestamp":1767923128,"startTime":"0","endTime":"0","summary":"证券之星1月9日盘中消息,9点43分创新医疗触及涨停板。其所属行业医疗服务目前上涨。领涨股为迪安诊断。该股为AI医疗,人工智能,民营医院概念热股,当日AI医疗概念上涨1.65%,人工智能概念上涨1.05%,民营医院概念上涨0.92%。1月8日的资金流向数据方面,主力资金净流入1.02亿元,占总成交额35.22%,游资资金净流出5346.07万元,占总成交额18.53%,散户资金净流出4813.44万元,占总成交额16.69%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900008568.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0114","002173","BK0077","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601533894","title":"宜明昂科与Axion“分手”;江西省卫健委党组书记被查","url":"https://stock-news.laohu8.com/highlight/detail?id=2601533894","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601533894?lang=zh_cn&edition=full","pubTime":"2026-01-08 08:41","pubTimestamp":1767832919,"startTime":"0","endTime":"0","summary":"政策动向国家药监局:优化临床急需境外已上市药品审评审批央视新闻消息显示,为加快临床急需境外已上市药品在境内上市,满足患者临床用药迫切需求,国家药监局进一步优化这类药品审评审批。国家药监局表示,坚持以临床价值为导向,鼓励申请人在中国开展全球同步研发、同步申报上市;鼓励临床急需境外已上市的原研药及仿制药在境内申报,对于符合要求的可纳入优先审评审批范围。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601083612141760.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601083612141760.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1328615791.USD","LU2097828631.EUR","LU2148510915.USD","LU1997245177.USD","BK0012","LU1255011170.USD","BK0183","LU1997244956.HKD","BK0196","LU0405327148.USD","LU1064130708.USD","BK0251","LU1580142542.USD","BK0077","LU0405327494.USD","002173","688321","BK0114","LU1969619763.USD","LU1146622755.USD","BK0060","LU2580892789.USD","BK0236","LU2289578879.USD","300653","LU2097828474.EUR","BK0096","LU1820825898.SGD","LU2488822045.USD","BK0046","BK0028","BK0188","LU2495084118.USD","LU2328871848.SGD","LU1655091616.SGD","LU1781817850.SGD","LU2580892862.HKD","LU1997245094.SGD","LU2097828557.USD","LU2097828805.USD","688759","600276","BK0239","LU1064131003.USD","LU2097828714.EUR"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778039753988,"stockEarnings":[{"period":"1week","weight":-0.0594},{"period":"1month","weight":-0.0666},{"period":"3month","weight":-0.1699},{"period":"6month","weight":-0.1088},{"period":"1year","weight":1.5393},{"period":"ytd","weight":0.0814}],"compareEarnings":[{"period":"1week","weight":0.0046},{"period":"1month","weight":0.0566},{"period":"3month","weight":-0.0014},{"period":"6month","weight":0.0398},{"period":"1year","weight":0.2541},{"period":"ytd","weight":0.0361}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"创新医疗管理股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"151022人(较上一季度增加33.86%)","perCapita":"2786股","listingDate":"2007-09-25","address":"浙江省绍兴市诸暨市山下湖镇郑家湖村","registeredCapital":"44128万元","survey":" 创新医疗管理股份有限公司的主营业务是提供医疗服务。公司的主要产品是医疗服务业务、其他业务。","listedPrice":11.3},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"创新医疗(002173)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供创新医疗(002173)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"创新医疗,002173,创新医疗股票,创新医疗股票老虎,创新医疗股票老虎国际,创新医疗行情,创新医疗股票行情,创新医疗股价,创新医疗股市,创新医疗股票价格,创新医疗股票交易,创新医疗股票购买,创新医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"创新医疗(002173)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供创新医疗(002173)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}